Target intelligence / Profile preview

Immunoglobulin heavy variable 1-3 (IGHV1-3)

Target
IGHV1-3
Molecular classification
Other (specifically, immunoglobulin variable region gene)
01

Overview

Immunoglobulin heavy variable 1-3 is a gene encoding the variable region of the heavy chain component of immunoglobulins (antibodies), which are key molecules of the adaptive immune system responsible for specific antigen recognition[1][6]. The product of IGHV1-3 forms part of the antigen binding site of immunoglobulin molecules—determining specificity and diversity of antibody responses via combination with corresponding light chain variable regions and through somatic mechanisms like V(D)J recombination and somatic hypermutation[1][7]. IGHV genes—including IGHV1-3—are not independent therapeutic targets or receptors but are structural genetic elements that contribute to the diversity and specificity of antibody-mediated immunity. Mutations or deletions in this and similar IGHV genes can impact immune repertoire and, in rare cases, be associated with immunological or developmental disorders[1][6].

Other names
IGHV1-3VI-3BIGHV13
02

Biological functions

Antigen bindingImmunoglobulin mediated immune responseHumoral immunity
03

Disease associations

Other (associated with Isolated Growth Hormone Deficiency, but generally not a direct disease target)

Beyond the preview

Go deeper on Immunoglobulin heavy variable 1-3 (IGHV1-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 1-3 (IGHV1-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call